IMUKIN

This brand name is authorized in Austria, Australia, Estonia, Spain, France, Malta

Active ingredients

The drug IMUKIN contains one active pharmaceutical ingredient (API):

1 Interferon gamma-1b
UNII 21K6M2I7AG - INTERFERON GAMMA-1B

It is presumed that interferon gamma-1b increases macrophage cytotoxicity by enhancing the respiratory burst via generation of toxic oxygen metabolites capable of mediating the killing of intracellular micro-organisms.

Read about Interferon gamma-1b

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L03AB03 Interferon gamma L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 5769P, 6148N
Country: EE Ravimiamet Identifier(s): 1681332, 1708657
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 60113
Country: FR Base de donnรฉes publique des mรฉdicaments Identifier(s): 67401121
Country: MT Medicines Authority Identifier(s): AA565/39303

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.